In addition, HAT1 is highly expressed in prostate cancer cells, and its overexpression is related to castration-resistant prostate cancer (CRPC) progression and the expression of androgen receptors (ARs), including full-length AR and AR variant 7 [70]. Here, AR is linked to prostate carcinoma.